Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Z Patt

Showing results (41-50 of 83) with videos related to

Pageof 9
Sort By:
American Journal of Clinical Oncology|June 17, 2000
Durable clinical response of refractory hepatocellular carcinoma to orally administered thalidomideY Z Patt, M M Hassan, R D Lozano, et al.
Clinical Immunology and Immunopathology|August 1, 1982
The immune restorative effect of cimetidine administration in vivo on the local graft-versus-host reaction of cancer patientsM Talpaz, J E Medina, Y Z Patt, et al.
AIDS Research|January 1, 1986
Effect of azimexon therapy on host defense parameters and disease-associated symptoms in the acquired immune deficiency syndrome (AIDS) and AIDS-related complex (ARC)Y Z Patt, P W Mansell, J M Reuben, et al.
Investigational New Drugs|August 11, 1992
Phase II study of didemnin B in advanced colorectal cancerD V Jones, J A Ajani, R Blackburn, et al.
Seminars in Nuclear Medicine|April 1, 1993
Imaging of colorectal carcinoma with technetium-99m radiolabeled Fab' fragmentsD A Podoloff, Y Z Patt, S A Curley, et al.
American Journal of Clinical Oncology|April 13, 1999
Durable clinical and pathologic response of hepatocellular carcinoma to systemic and hepatic arterial administration of platinol, recombinant interferon alpha 2B, doxorubicin, and 5-fluorouracil: a communicationY Z Patt, A Hoque, M Roh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1996
Phase II trial of intravenous flourouracil and subcutaneous interferon alfa-2b for biliary tract cancerY Z Patt, D V Jones, A Hoque, et al.
Nutrition and Cancer|January 7, 2000
Does aflatoxin B1 play a role in the etiology of hepatocellular carcinoma in the United States?A Hoque, Y Z Patt, B Yoffe, et al.
Annals of Surgical Oncology|August 18, 2000
Surgery after downstaging of unresectable hepatic tumors with intra-arterial chemotherapyF Meric, Y Z Patt, S A Curley, et al.
Annals of Surgery|December 6, 1997
Use of carcinoembryonic antigen radioimmunodetection and computed tomography for predicting the resectability of recurrent colorectal cancerK Hughes, C M Pinsky, N J Petrelli, et al.
Pageof 9

Showing results (41-50 of 83) with videos related to

Sort By:
Pageof 9
American Journal of Clinical Oncology|June 17, 2000
Durable clinical response of refractory hepatocellular carcinoma to orally administered thalidomideY Z Patt, M M Hassan, R D Lozano, et al.
Clinical Immunology and Immunopathology|August 1, 1982
The immune restorative effect of cimetidine administration in vivo on the local graft-versus-host reaction of cancer patientsM Talpaz, J E Medina, Y Z Patt, et al.
AIDS Research|January 1, 1986
Effect of azimexon therapy on host defense parameters and disease-associated symptoms in the acquired immune deficiency syndrome (AIDS) and AIDS-related complex (ARC)Y Z Patt, P W Mansell, J M Reuben, et al.
Investigational New Drugs|August 11, 1992
Phase II study of didemnin B in advanced colorectal cancerD V Jones, J A Ajani, R Blackburn, et al.
Seminars in Nuclear Medicine|April 1, 1993
Imaging of colorectal carcinoma with technetium-99m radiolabeled Fab' fragmentsD A Podoloff, Y Z Patt, S A Curley, et al.
American Journal of Clinical Oncology|April 13, 1999
Durable clinical and pathologic response of hepatocellular carcinoma to systemic and hepatic arterial administration of platinol, recombinant interferon alpha 2B, doxorubicin, and 5-fluorouracil: a communicationY Z Patt, A Hoque, M Roh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1996
Phase II trial of intravenous flourouracil and subcutaneous interferon alfa-2b for biliary tract cancerY Z Patt, D V Jones, A Hoque, et al.
Nutrition and Cancer|January 7, 2000
Does aflatoxin B1 play a role in the etiology of hepatocellular carcinoma in the United States?A Hoque, Y Z Patt, B Yoffe, et al.
Annals of Surgical Oncology|August 18, 2000
Surgery after downstaging of unresectable hepatic tumors with intra-arterial chemotherapyF Meric, Y Z Patt, S A Curley, et al.
Annals of Surgery|December 6, 1997
Use of carcinoembryonic antigen radioimmunodetection and computed tomography for predicting the resectability of recurrent colorectal cancerK Hughes, C M Pinsky, N J Petrelli, et al.
Pageof 9